SCHEMBL3921265

SCHEMBL3921265

N=C1NC(=O)C(CC(=O)NCc2ccccc2)S1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.60
LMNA P02545 2/20 0.60
MAOB P27338 1/20 0.59
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
HTT P42858 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.49
POLB P06746 2/20 0.48
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
MAPT P10636 1/20 0.47
EGFR P00533 1/20 0.46
SRC P12931 1/20 0.46
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3923346 0.87 MAPT (0.53) ALDH1A1LMNAMAOBMEN1KMT2A
SCHEMBL3915221 0.86 HTT (0.72) ALDH1A1LMNAMAOBMEN1KMT2A
SCHEMBL3922167 0.84 MEN1 (0.47) ALDH1A1LMNAMAOBMEN1KMT2A
SCHEMBL3923245 0.83 HTT (0.52) ALDH1A1LMNAMAOBMEN1KMT2A
SCHEMBL4175139 0.82 KMT2A (0.78) ALDH1A1LMNAMEN1KMT2AHTT
SCHEMBL3913448 0.81 MAPT (0.58) ALDH1A1LMNAMAOBMEN1KMT2A
SCHEMBL7492042 0.77 POLB (0.66) ALDH1A1LMNAMEN1KMT2AHTT
SCHEMBL7492048 0.77 POLB (0.66) ALDH1A1LMNAMEN1KMT2AHTT
SCHEMBL1520824 0.75 MAOB (1.00) ALDH1A1LMNAMAOBMEN1KMT2A
SCHEMBL3917727 0.72 MAPT (0.62) ALDH1A1MAOBMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060270720-A1 Iminothiazolidinone derivatives as SFRP-1 antagonists WYETH (US) 2006-11-30 US claimed
US-7563813-B2 Iminothiazolidinone derivatives as SFRP-1 antagonists WYETH (US) 2009-07-21 US disclosed
US-20060270720-A1 Iminothiazolidinone derivatives as SFRP-1 antagonists WYETH (US) 2006-11-30 US disclosed
WO-2006124887-A1 IMINOTHIAZOLIDINONE DERIVATIVES AS SFRP-1 ANTAGONISTS WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270720-A1 Iminothiazolidinone derivatives as SFRP-1 antagonists SFRP1, FZD7, DKK1 ALDH1A1 683/4885LMNA 4353/4885MAOB 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.